Interventional Oncology Market Size, Status, Growth | Industry Analysis Report 2020-2028

The newly added research report by Value Market Research disclose all the important information associated with the market such as value, growth factor, trends, market share, size, and challenges for the forecasted timeline 2020-2028. Further, this report also highlights smart strategy adopted by major players and also their market share. Basically, this report is designed to give a proper understanding of industry structure and competition intensity attractiveness.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the interventional oncology market include Boston Scientific Corporation, C. R. Bard, Inc., Medtronic plc, Cook Medical LLC, Merit Medical Systems, Inc., Profound Medical Corp, AngioDynamics, Inc., BTG plc, Terumo Corporation, HealthTronics, Inc., EDAP TMS S.A., Neuwave Medical, Inc., Sirtex Medical Limited, Trod Medical, Teleflex Incorporated, Sanarus Technologies Inc., IMBiotechnologies Ltd., MedWaves, Inc., and IceCure Medical Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Market Dynamics
The rising demand for minimally invasive therapeutics is the key driving factor for the market growth. These procedures could also be used to treat patients with other related comorbidities and in inoperable patients. The capability of minimally invasive techniques to treat cancerous cells better than alternative cancer treatments such as radiation therapy, surgeries, and systematic chemotherapy has helped the technique acquire popularity. Furthermore, healthcare professionals and patients are gradually opting for minimally invasive procedures in the field of interventional oncology due to advantages of using these techniques such as shorter hospital stay, minimal risk of infection, minimal risk of complications, cause less pain, and faster recovery time in comparison to conventional surgeries. These advantages of using minimally invasive procedures will drive market growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of interventional oncology.
Market Segmentation
The entire interventional oncology market has been sub-categorized into procedure, product, application and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Procedure
1. Tumor Embolization
· Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy
· Transcatheter Arterial Chemoembolization (TACE)
· Transcatheter Arterial Embolization/Bland Embolization
2. Tumor Ablation
I. Thermal Ablation
· Microwave Ablation
· Radiofrequency Ablation
· Cryoablation
· Others (Laser and HIFU)
II. Non-Thermal Ablation
· Irreversible Electroporation
By Product
1. Tumor Embolization
I. Radioembolic Agents
· SIR-Spheres
· TheraSphere
· QuiremSpheres
II. Non-Radioactive Embolic Agents
· Microspheres
· Drug-eluting beads
· Particles
III. Tumor Ablation
· Capital Ablation Devices/Generators
· Consumables & Accessories
By Application
· Liver Cancer
· Lung Cancer
· Breast Cancer
· Prostate Cancer
· Kidney Cancer
· Bone Metastasis
· Others
By End User
· Hospital
· Ambulatory Care Centers
· Research & Academia
Browse Global Interventional Oncology Market Research Report with detailed TOC at
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for interventional oncology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Want to print your doc?
This is not the way.
Try clicking the ⋯ next to your doc name or using a keyboard shortcut (
) instead.